nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—Myopia—Varenicline—nicotine dependence	0.0705	0.0937	CcSEcCtD
Atropine—Balance disorder—Varenicline—nicotine dependence	0.0282	0.0374	CcSEcCtD
Atropine—Paranoia—Varenicline—nicotine dependence	0.0226	0.03	CcSEcCtD
Atropine—Mania—Varenicline—nicotine dependence	0.0212	0.0281	CcSEcCtD
Atropine—Mydriasis—Varenicline—nicotine dependence	0.0193	0.0256	CcSEcCtD
Atropine—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.017	0.0226	CcSEcCtD
Atropine—Ventricular extrasystoles—Varenicline—nicotine dependence	0.017	0.0226	CcSEcCtD
Atropine—Leukocytosis—Varenicline—nicotine dependence	0.0164	0.0218	CcSEcCtD
Atropine—Dysarthria—Varenicline—nicotine dependence	0.0163	0.0216	CcSEcCtD
Atropine—Blood pressure increased—Varenicline—nicotine dependence	0.0154	0.0205	CcSEcCtD
Atropine—Photophobia—Varenicline—nicotine dependence	0.0145	0.0192	CcSEcCtD
Atropine—Dry eye—Varenicline—nicotine dependence	0.0142	0.0189	CcSEcCtD
Atropine—Hypertonia—Varenicline—nicotine dependence	0.0135	0.0179	CcSEcCtD
Atropine—Disorientation—Varenicline—nicotine dependence	0.0125	0.0166	CcSEcCtD
Atropine—Eczema—Varenicline—nicotine dependence	0.0124	0.0165	CcSEcCtD
Atropine—Eye pain—Varenicline—nicotine dependence	0.0124	0.0164	CcSEcCtD
Atropine—Amnesia—Varenicline—nicotine dependence	0.0119	0.0158	CcSEcCtD
Atropine—Atrial fibrillation—Varenicline—nicotine dependence	0.0118	0.0157	CcSEcCtD
Atropine—Thirst—Varenicline—nicotine dependence	0.0117	0.0156	CcSEcCtD
Atropine—Hypoglycaemia—Varenicline—nicotine dependence	0.0114	0.0152	CcSEcCtD
Atropine—Lethargy—Varenicline—nicotine dependence	0.0114	0.0152	CcSEcCtD
Atropine—Osteoarthritis—Varenicline—nicotine dependence	0.0112	0.0148	CcSEcCtD
Atropine—Psychotic disorder—Varenicline—nicotine dependence	0.0109	0.0145	CcSEcCtD
Atropine—Irritability—Varenicline—nicotine dependence	0.0107	0.0142	CcSEcCtD
Atropine—Urinary retention—Varenicline—nicotine dependence	0.0106	0.0141	CcSEcCtD
Atropine—Dry skin—Varenicline—nicotine dependence	0.0102	0.0136	CcSEcCtD
Atropine—Hypokalaemia—Varenicline—nicotine dependence	0.0102	0.0135	CcSEcCtD
Atropine—Abdominal distension—Varenicline—nicotine dependence	0.00972	0.0129	CcSEcCtD
Atropine—Dysphagia—Varenicline—nicotine dependence	0.00966	0.0128	CcSEcCtD
Atropine—Angina pectoris—Varenicline—nicotine dependence	0.00941	0.0125	CcSEcCtD
Atropine—Erectile dysfunction—Varenicline—nicotine dependence	0.00889	0.0118	CcSEcCtD
Atropine—Hyperglycaemia—Varenicline—nicotine dependence	0.00871	0.0116	CcSEcCtD
Atropine—Depression—Varenicline—nicotine dependence	0.00859	0.0114	CcSEcCtD
Atropine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00849	0.0113	CcSEcCtD
Atropine—Myocardial infarction—Varenicline—nicotine dependence	0.00844	0.0112	CcSEcCtD
Atropine—Conjunctivitis—Varenicline—nicotine dependence	0.00837	0.0111	CcSEcCtD
Atropine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00805	0.0325	CbGpPWpGaD
Atropine—Bradycardia—Varenicline—nicotine dependence	0.00787	0.0105	CcSEcCtD
Atropine—Hallucination—Varenicline—nicotine dependence	0.00769	0.0102	CcSEcCtD
Atropine—CHRM4—Monoamine GPCRs—DRD2—nicotine dependence	0.00749	0.0303	CbGpPWpGaD
Atropine—CHRM5—Monoamine GPCRs—DRD2—nicotine dependence	0.00717	0.029	CbGpPWpGaD
Atropine—Arrhythmia—Varenicline—nicotine dependence	0.0069	0.00918	CcSEcCtD
Atropine—Mental disorder—Varenicline—nicotine dependence	0.00677	0.009	CcSEcCtD
Atropine—Erythema—Varenicline—nicotine dependence	0.00673	0.00894	CcSEcCtD
Atropine—Dysgeusia—Varenicline—nicotine dependence	0.00659	0.00876	CcSEcCtD
Atropine—Vision blurred—Varenicline—nicotine dependence	0.00634	0.00843	CcSEcCtD
Atropine—CHRM4—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0063	0.0254	CbGpPWpGaD
Atropine—Agitation—Varenicline—nicotine dependence	0.00618	0.00822	CcSEcCtD
Atropine—Angioedema—Varenicline—nicotine dependence	0.00615	0.00817	CcSEcCtD
Atropine—Vertigo—Varenicline—nicotine dependence	0.00605	0.00803	CcSEcCtD
Atropine—Syncope—Varenicline—nicotine dependence	0.00603	0.00802	CcSEcCtD
Atropine—CHRM5—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00603	0.0244	CbGpPWpGaD
Atropine—Palpitations—Varenicline—nicotine dependence	0.00595	0.0079	CcSEcCtD
Atropine—Loss of consciousness—Varenicline—nicotine dependence	0.00591	0.00786	CcSEcCtD
Atropine—Convulsion—Varenicline—nicotine dependence	0.00583	0.00775	CcSEcCtD
Atropine—CHRM4—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00577	0.0233	CbGpPWpGaD
Atropine—Chest pain—Varenicline—nicotine dependence	0.00573	0.00761	CcSEcCtD
Atropine—Anxiety—Varenicline—nicotine dependence	0.00571	0.00759	CcSEcCtD
Atropine—Dry mouth—Varenicline—nicotine dependence	0.0056	0.00745	CcSEcCtD
Atropine—CHRM5—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00553	0.0223	CbGpPWpGaD
Atropine—Oedema—Varenicline—nicotine dependence	0.00549	0.0073	CcSEcCtD
Atropine—Shock—Varenicline—nicotine dependence	0.0054	0.00718	CcSEcCtD
Atropine—Tachycardia—Varenicline—nicotine dependence	0.00536	0.00712	CcSEcCtD
Atropine—Hyperhidrosis—Varenicline—nicotine dependence	0.00531	0.00706	CcSEcCtD
Atropine—Hypotension—Varenicline—nicotine dependence	0.00513	0.00682	CcSEcCtD
Atropine—CHRM4—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00511	0.0206	CbGpPWpGaD
Atropine—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00505	0.0204	CbGpPWpGaD
Atropine—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.00503	0.0203	CbGpPWpGaD
Atropine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00499	0.0201	CbGpPWpGaD
Atropine—Insomnia—Varenicline—nicotine dependence	0.00497	0.0066	CcSEcCtD
Atropine—Dyspnoea—Varenicline—nicotine dependence	0.0049	0.00651	CcSEcCtD
Atropine—Somnolence—Varenicline—nicotine dependence	0.00488	0.00649	CcSEcCtD
Atropine—Dyspepsia—Varenicline—nicotine dependence	0.00483	0.00642	CcSEcCtD
Atropine—Fatigue—Varenicline—nicotine dependence	0.00473	0.00629	CcSEcCtD
Atropine—Constipation—Varenicline—nicotine dependence	0.0047	0.00624	CcSEcCtD
Atropine—Pain—Varenicline—nicotine dependence	0.0047	0.00624	CcSEcCtD
Atropine—Feeling abnormal—Varenicline—nicotine dependence	0.00453	0.00601	CcSEcCtD
Atropine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00449	0.00597	CcSEcCtD
Atropine—Urticaria—Varenicline—nicotine dependence	0.00436	0.0058	CcSEcCtD
Atropine—Abdominal pain—Varenicline—nicotine dependence	0.00434	0.00577	CcSEcCtD
Atropine—Body temperature increased—Varenicline—nicotine dependence	0.00434	0.00577	CcSEcCtD
Atropine—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00425	0.0171	CbGpPWpGaD
Atropine—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00423	0.0171	CbGpPWpGaD
Atropine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00419	0.0169	CbGpPWpGaD
Atropine—Hypersensitivity—Varenicline—nicotine dependence	0.00405	0.00538	CcSEcCtD
Atropine—Asthenia—Varenicline—nicotine dependence	0.00394	0.00524	CcSEcCtD
Atropine—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00389	0.0157	CbGpPWpGaD
Atropine—Pruritus—Varenicline—nicotine dependence	0.00389	0.00516	CcSEcCtD
Atropine—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00388	0.0157	CbGpPWpGaD
Atropine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00384	0.0155	CbGpPWpGaD
Atropine—Diarrhoea—Varenicline—nicotine dependence	0.00376	0.00499	CcSEcCtD
Atropine—Dizziness—Varenicline—nicotine dependence	0.00363	0.00483	CcSEcCtD
Atropine—CHRM4—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00359	0.0145	CbGpPWpGaD
Atropine—Vomiting—Varenicline—nicotine dependence	0.00349	0.00464	CcSEcCtD
Atropine—Rash—Varenicline—nicotine dependence	0.00346	0.0046	CcSEcCtD
Atropine—Dermatitis—Varenicline—nicotine dependence	0.00346	0.0046	CcSEcCtD
Atropine—CHRM4—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00344	0.0139	CbGpPWpGaD
Atropine—CHRM5—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00344	0.0139	CbGpPWpGaD
Atropine—Headache—Varenicline—nicotine dependence	0.00344	0.00457	CcSEcCtD
Atropine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0034	0.0137	CbGpPWpGaD
Atropine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00334	0.0135	CbGpPWpGaD
Atropine—CHRM5—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.0033	0.0133	CbGpPWpGaD
Atropine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0033	0.0133	CbGpPWpGaD
Atropine—Nausea—Varenicline—nicotine dependence	0.00326	0.00434	CcSEcCtD
Atropine—CHRM4—GPCR ligand binding—TAS2R16—nicotine dependence	0.00309	0.0125	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—TAS2R16—nicotine dependence	0.00296	0.012	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00292	0.0118	CbGpPWpGaD
Atropine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00271	0.0109	CbGpPWpGaD
Atropine—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00242	0.00979	CbGpPWpGaD
Atropine—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00242	0.00976	CbGpPWpGaD
Atropine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00239	0.00966	CbGpPWpGaD
Atropine—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00232	0.00938	CbGpPWpGaD
Atropine—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00232	0.00935	CbGpPWpGaD
Atropine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00229	0.00926	CbGpPWpGaD
Atropine—CHRM4—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00215	0.0087	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00209	0.00843	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00208	0.0084	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00206	0.00832	CbGpPWpGaD
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.002	0.00808	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00195	0.00786	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00191	0.00773	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00177	0.00714	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00175	0.00706	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00171	0.00692	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00167	0.00676	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00164	0.00663	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00161	0.0065	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—TAS2R16—nicotine dependence	0.00159	0.00641	CbGpPWpGaD
Atropine—CHRM4—G alpha (i) signalling events—DRD2—nicotine dependence	0.00156	0.00629	CbGpPWpGaD
Atropine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00153	0.00617	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—TAS2R16—nicotine dependence	0.00152	0.00614	CbGpPWpGaD
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00145	0.00584	CbGpPWpGaD
Atropine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00144	0.00581	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00143	0.00579	CbGpPWpGaD
Atropine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00142	0.00573	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00138	0.00559	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—FGD1—nicotine dependence	0.00137	0.00554	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00135	0.00544	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00134	0.00543	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00133	0.00537	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—FGD1—nicotine dependence	0.00131	0.00531	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—OPRM1—nicotine dependence	0.0013	0.00527	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—OPRM1—nicotine dependence	0.00125	0.00505	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—FGD1—nicotine dependence	0.00125	0.00503	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00124	0.005	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—FGD1—nicotine dependence	0.00119	0.00482	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.00119	0.00481	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00119	0.00479	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00118	0.00476	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00118	0.00475	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00116	0.0047	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00115	0.00466	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00115	0.00465	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00114	0.0046	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00107	0.00432	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00107	0.00431	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00106	0.00427	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00104	0.00419	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000975	0.00394	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000971	0.00392	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000962	0.00389	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—DRD2—nicotine dependence	0.000943	0.00381	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TAS2R16—nicotine dependence	0.000938	0.00379	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000925	0.00374	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000922	0.00372	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000913	0.00369	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—DRD2—nicotine dependence	0.000903	0.00365	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	0.000898	0.00363	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000879	0.00355	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000877	0.00354	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000868	0.00351	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.00084	0.00339	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000837	0.00338	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000835	0.00337	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000832	0.00336	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000829	0.00335	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000824	0.00333	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—OPRM1—nicotine dependence	0.000737	0.00298	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—FGD1—nicotine dependence	0.000736	0.00297	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	0.000706	0.00285	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—FGD1—nicotine dependence	0.000705	0.00285	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	0.000669	0.0027	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	0.00065	0.00263	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	0.000641	0.00259	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000636	0.00257	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.000634	0.00256	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000632	0.00255	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.00063	0.00255	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000628	0.00254	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000624	0.00252	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	0.000623	0.00251	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	0.000533	0.00215	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	0.00051	0.00206	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000497	0.00201	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000496	0.002	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000495	0.002	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000495	0.002	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000491	0.00198	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.00049	0.00198	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000486	0.00196	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	0.000484	0.00195	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	0.000463	0.00187	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—WASF2—nicotine dependence	0.000458	0.00185	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000451	0.00182	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.00045	0.00182	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000446	0.0018	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—WASF1—nicotine dependence	0.000439	0.00177	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—WASF2—nicotine dependence	0.000439	0.00177	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000438	0.00177	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000437	0.00177	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000433	0.00175	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—WASF1—nicotine dependence	0.000421	0.0017	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	0.000395	0.0016	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	0.000379	0.00153	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000359	0.00145	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000358	0.00145	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000355	0.00143	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000326	0.00132	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000325	0.00131	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000322	0.0013	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000309	0.00125	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000308	0.00124	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000305	0.00123	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000296	0.0012	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000295	0.00119	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000292	0.00118	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—DRD2—nicotine dependence	0.000286	0.00115	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—DRD2—nicotine dependence	0.000274	0.00111	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000267	0.00108	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000266	0.00107	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000263	0.00106	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000246	0.000994	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000193	0.000779	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000192	0.000776	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.00019	0.000769	CbGpPWpGaD
